Navigation Links
Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
Date:2/9/2011

TARRYTOWN, N.Y., Feb. 9, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that it will webcast an investor briefing on Sunday, February 13 from 9 a.m. to 10:30 a.m. Eastern Time.  At the investor briefing, principal investigators from the VEGF Trap-Eye clinical studies will recap presentations from the Bascom Palmer Eye Institute's Angiogenesis, Exudation and Degeneration 2011 meeting being held in Miami, Florida on Saturday, February 12.  

The investigator presentations will provide additional data from the VIEW 1 and VIEW 2 Phase 3 trials in patients with the neovascular form of age-related macular degeneration (wet AMD), the COPERNICUS Phase 3 trial in macular edema due to central retinal vein occlusion (CRVO), and the DA VINCI Phase 2 trial in diabetic macular edema (DME).  Regeneron reported positive top-line results from all these trials in the fourth quarter of 2010.

"It's a privilege to be able to release this important collection of VEGF Trap-Eye data at the Bascom Palmer Eye Institute's Eighth Annual Angiogenesis Meeting," said  Philip J. Rosenfeld, M.D., Ph.D., Professor of Ophthalmology, University of Miami Miller School of Medicine and Course Co-Director of the Angiogenesis 2011 Meeting.  "In particular, the Phase 3 results in wet AMD suggest that the VEGF Trap-Eye has the potential to address an important unmet need of providing optimal vision gain while reducing the burden of intravitreal injections and office visits for patients and their caregivers."  

The webcast and slides may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page (http://investor.regeneron.com).  An archived version of the presentation will be available after the live webcast through M
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regeneron Announces Presentation at the ISI Annual Conference
2. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
3. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
4. Christine A. Poon Elected to Regeneron Board of Directors
5. Regeneron Announces Presentation at the 2010 Credit Suisse Annual Healthcare Conference
6. Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference
7. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
8. Regeneron Increases Size of Public Offering of Common Stock
9. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
10. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
11. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Clinicient Inc , a leader ... results of an industry survey of how efficiently ... practice owners and administrative staff completed the brand-neutral ... technology and services that improve therapist efficiency. ... published a free 12-page guide to help physical ...
(Date:5/26/2015)... , May 26, 2015  EndoChoice today announced the ... of its common stock, which will represent 25.6% of ... Delaware corporation in connection with ... estimated to be between $15 and $17 per share. ... 30-day option to purchase up to an additional 937,500 ...
(Date:5/26/2015)... , May 26, 2015 ... technology,s commercial potential ,What,s the future of technologies ... commercial predictions from 2015. Stay ahead there for ... you explore sales results, R&D, opportunities and revenue ... visiongain shows you what,s possible for ...
Breaking Medicine Technology:Survey: Half of Physical Therapists Underbill For Their Services 2EndoChoice Announces Launch of Its Initial Public Offering 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7
(Date:5/26/2015)... Securityhunter has been awarded a ... States Department of Health and Human Services (HHS) through ... was awarded through the General Services Administration (GSA) Multiple ... which is a fee-for-service agency. The award is for ... is an enterprise–wide physical security and security system integration ...
(Date:5/26/2015)... Platte, LA (PRWEB) May 26, 2015 ... readers along with her as she writes an unforgettable ... difficult challenges in her life. The first black student ... was harassed and beaten by some students, treated harshly ... white woman. A motivating personal phone conversation with Dr. ...
(Date:5/26/2015)... Over 700 doctors, nutritionists, nurses, and ... the secretaries of the U.S. Department of Agriculture and ... them to embrace the 2015 Dietary Guidelines Advisory Committee’s ... human health, economic prosperity, and our nation’s food security. ... letter, including: Dr. David Katz, founding director of the ...
(Date:5/26/2015)... 26, 2015 The American College of Traditional ... for the Open House/Free Application Day on Wednesday, July 22. ... 4 p.m. and will be held at ACTCM Pioneer Square, ... After checking in, attendees will be greeted with an introduction ... of the campus at 11:45 a.m. Lunch will be served ...
(Date:5/26/2015)... Irwin Gross, M.D., Accumen, Inc.’s ... Patient Blood Management (PBM) initiative at Eastern Maine Medical ... by more than 60 percent and improved patient outcomes ... in an article in the May 2015 edition of ... red cell loss, less acute kidney injury and cut ...
Breaking Medicine News(10 mins):Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 3Health News:ACTCM to Host Summer Open House 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3
... - Patients with an implantable cardioverter defibrillator did not ... rhythms// or death by consuming fish oil supplements, which ... to a study in the June 14 issue of ... approximately 50 percent of all death from cardiovascular disease ...
... that the number of violent attacks on hospital staff ... According to the figures that were released by the ... had reported 224 incidents of violence, which is an ... represents the health workers, says that violence against staff ...
... of New Zealanders who take party pills in higher doses ... party pills escape people from taking drugs. ,Nearly ... atleast once – says researchers commissioned by the Ministry of ... parts such as sleeplessness, loss of appetite, strange thoughts and ...
... Prozac has been cleared for treating children over eight years ... its use//. ,The conditions imposed by the European ... only when other therapies have failed. "Prozac should only be ... therapy alone after four to six sessions," said the EMEA. ...
... Taking vitamin E supplements during pregnancy may lead to ... ,Vitamin E is an anti-oxidant found naturally in foods ... suggested that vitamin E, particularly taken with vitamin C, ... ,However, Andrew Shennan, who led a two-year study ...
... A report on the Journal of General Dentistry reveals ... bone cancer therapies are supposed //to take drugs that ... osteonecrosis of the jaws (a rotting of the jaw ... used to prevent and treat osteoporosis, multiple myeloma, Paget’s ...
Cached Medicine News:Health News:Fish Oil does not Appear to Protect Against Abnormal Heart Rhythms 2Health News:Violence Against NHS Staff On The Raise 2Health News:Drugs With Bisphosphonates Packs Osteonecrosis Risk 2
Used for retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
Used for directing a flexible tipped wire guide in the ureter. The angled tip allows passage of the catheter past a ureteral stone in preparation for E.S.W.L. Supplied sterile in peel-open packages. ...
These flexible stone retrieval devices are reusable, 3 Fr in diameter, with a working length of either 60 cm or 115 cm...
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
Medicine Products: